NCCN Guidelines for Patients® | Myelodysplastic Syndromes – For Patients | – For Clinicians NCCN Foundation ® gratefully acknowledges our advocacy supporter Aplastic Anemia and MDS International Foundation (AAMDSIF) and our industry supporter Amgen, Inc., for their support in making available these NCCN Guidelines for Patients ® . NCCN independently develops and distributes the NCCN Guidelines for Patients. Our industry supporters do not participate in the development of the NCCN Guidelines for Patients and are not responsible for the content and recommendations contained therein. PAT-N-1006-0917 Myelodysplastic Syndromes 2018 275 Commerce Drive Suite 300 Fort Washington, PA 19034 215.690.0300 NCCN GUIDELINES FOR PATIENTS ®